WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Centessa Pharmaceuticals earnings were -$250.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CNTA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$79.2M, up 19.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CNTA reported annual earnings of -$197.5M, with -16.2% growth.

CNTA earnings history

Current Revenue
$0.0
Current Earnings
-$250.6M
Current Profit Margin
0%

CNTA Return on Equity

Current Company
-60.4%
Current Industry
-141.9%
Current Market
13.5%
CNTA's Return on Equity (-60.4%)... subscribe to Premium to read more.
High Return on Equity Performance

CNTA Return on Assets

Current Company
-44.2%
Current Industry
-13.7%
CNTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CNTA announces earnings.

CNTA Return on Capital Employed

Current Company
-39.34%
Current Industry
-9.5%
CNTA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNTA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CNTA-$237.11M-$250.64MN/A-$1.79
LQDA$53.57M$22.31MN/A$0.24
COGT-$345.43M-$354.30MN/A-$2.17
MIRM-$756.09M-$798.84MN/A-$13.61
PTCT-$14.06M-$186.73MN/A-$2.48
View Top Biotech Stocks

Centessa Pharmaceuticals Earnings Reports & History FAQ

What were Centessa Pharmaceuticals's earnings last quarter?

On CNTA's earnings call on Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q1 2026 earnings per share (EPS) of -$0.52, up 160% year over year. Total CNTA earnings for the quarter were -$79.24 million. In the same quarter last year, Centessa Pharmaceuticals's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.

Is Centessa Pharmaceuticals profitable or losing money?

As of the last Centessa Pharmaceuticals earnings report, Centessa Pharmaceuticals is currently losing money. Centessa Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$250.64 million, a 11.97% increase year over year.

What was CNTA's earnings growth in the past year?

As of Centessa Pharmaceuticals's earnings date in Invalid Date, Centessa Pharmaceuticals's earnings has grown year over year. CNTA earnings in the past year totalled -$250.64 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.